10x Genomics Denmark ApS: Financial statements 2024
CVR: 40243224
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,416,395 and a net result of DKK 183,445 compared with DKK -586,583 the year before. That is an increase of 65.9% compared with the year before. Equity in the 2024 report amounted to DKK 818,784. The solvency ratio was 57.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,416,395
- Profit/Loss
- DKK 183,445
- Equity
- DKK 818,784
- Total Assets
- DKK 1,430,270
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.4 mio. | 183 t. | 819 t. | 2 |
| 2023 | - | 2.1 mio. | -587 t. | 635 t. | 2 |
| 2022 | - | 7.3 mio. | 2.8 mio. | 1.2 mio. | 5 |
| 2021 | - | 52.2 mio. | 39.8 mio. | 38.4 mio. | 2 |
| 2020 | - | -1.6 mio. | -2 mio. | -1.4 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of August 28, 2024, Adam Samuel Taich is registered as director of 10x Genomics Denmark ApS.
As of August 28, 2024, Justin John McAnear has stepped down as director of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS has published its annual report for 2023. Gross profit came to DKK 2,058,991, and the net result was DKK -586,583.
10x Genomics Denmark ApS has won the tender "Cytassist - 2024-0687771" issued by Aarhus Universitet worth 96,851 EUR.
About 10x Genomics Denmark ApS
10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.